한글목차

세계의 NGS 타겟 인리치먼트 프로브 시장 전망은 바이오사이언스 기업, 대학 및 연구기관 및 기타 시장에서의 기회로 유망시되고 있습니다. 세계 NGS 타겟 인리치먼트 프로브 시장은 2025-2031년까지 연평균 복합 성장률(CAGR) 17.1%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 맞춤형 의료 및 정밀 유전자 검사 수요 증가, 유전체 연구의 진보가 타겟 시퀀싱 기술의 채택을 촉진하는 것입니다.

• Lucintel의 예측에서 유형별로는 칩 프로브가 예측 기간 중에 높은 성장을 이룰 전망입니다.
• 용도별로는 바이오사이언스 기업의 고성장이 예상됩니다.
• 지역별로는 아시아태평양이 예측기간 중 가장 높은 성장이 예상됩니다.

NGS 타겟 인리치먼트 프로브 시장 동향

세계의 NGS 타겟 인리치먼트 프로브 시장은 유전체 연구와 기술의 진보를 반영하는 몇 가지 새로운 동향에 의해 진화하고 있습니다. 이러한 추세는 임상 진단에서 유전체학 및 맞춤형 의료 연구에 이르기까지 다양한 응용 분야에서 보다 빠르고, 정확하며, 비용 효율적인 시퀀싱 솔루션에 대한 수요 증가에 대응하는 데 도움이 됩니다.

• 개인화 의료의 시작 : 정밀의료가 보급됨에 따라 타겟 강화 프로브에 대한 수요가 증가하고 있습니다. 이러한 프로브는 특정 질병과 관련된 유전자를 보다 정확하게 시퀀싱할 수 있게 하며, 암과 유전성 질환과 같은 맞춤 치료 전략을 가능하게 합니다. 이 트렌드는 특이성이 높고 효율적인 NGS 프로브의 필요성을 높이고 있습니다.
• 프로브 설계의 기술적 진보 : 프로브 디자인과 화학의 상당한 개선으로 NGS 타겟 인리치먼트의 성능이 향상되었습니다. 더 나은 프로브의 하이브리드화와 증폭을 위한 새로운 기술은 유전체 시퀀싱에서 더 높은 감도, 정확성및 범위로 이어지고 있습니다. 이는 보다 빠르고 비용 효율적인 시퀀싱에 기여하며 NGS 워크플로우의 전반적인 효율성을 향상시킵니다.
• 종양 용도에 대한 관심 증가 : 암 유전학은 NGS 타겟 인리치먼트 프로브 수요를 견인하는 주요 요인 중 하나입니다. 암의 유전적 기반에 관한 조사 증가에 따라 암 유전자, 암 억제 유전자, 암과 관련된 변이를 특이적으로 표적으로 하도록 설계된 프로브에 대한 요구가 높아지고 있습니다. 이 초점은 다양한 암종에 맞는 프로브 개발을 뒷받침합니다.
• 액체생검과의 통합 : NGS 타겟 인리치먼트 프로브와 액체생검 기술의 통합은 암의 진단과 모니터링에 혁명을 일으키고 있습니다. 액체생검는 혈액으로부터 종양 DNA를 비침습적으로 채취할 수 있으며, 이 과정에서 인리치먼트 프로브를 사용하여 유전자 변이를 검출할 수 있어 암의 조기 발견과 모니터링에 큰 이점을 가져옵니다.
• 감염성 연구의 성장 : 감염, 특히 COVID-19와 같은 바이러스성 감염의 유행이 증가하는 것은 병원체 검출을 위한 NGS의 사용을 촉진하고 있습니다. 바이러스 유전체를 특이적으로 강화하는 타겟 인리치먼트 프로브가 개발되어, 감염, 변이, 바이러스량을 보다 신속하고 정확하게 검출할 수 있게 되어, 세계적인 공중 보건 활동에 도움이 되고 있습니다.

맞춤형 의료 확대, 프로브 설계 기술 혁신, 종양학 특화된 용도, 액체생검와의 통합, 감염증 연구 등 이러한 새로운 동향이 NGS 타겟 인리치먼트 프로브 시장 전망를 형성하고 있습니다. 이러한 진보로 유전체 시퀀싱의 가속화, 고정밀도, 접근성 향상, 환자의 결과 개선, 유전체 의료 분야가 진전되고 있습니다.

NGS 타겟 인리치먼트 프로브 시장의 최근 동향

NGS 타겟 인리치먼트 프로브 시장의 최근 동향은 유전체 연구와 임상 진단의 급속한 진보를 반영합니다. 프로브의 화학, 설계 및 기술 혁신은 NGS의 성능을 향상시키고 종양학, 감염증 연구, 유전자 검사 등 다양한 산업 분야에서 수요를 촉진하고 있습니다.

• 프로브 성능 향상 : 각 회사는 NGS 워크플로우에서 감도, 특이성 및 범위를 향상시키는 차세대 프로브를 발표하고 있습니다. 이러한 개발은 특히 복잡한 유전체 영역에서 보다 정확한 시퀀싱 결과를 제공하고 유전성 질환과 암의 진단 능력을 향상시키는 것을 목적으로 하고 있습니다.
• 암 특이적 인리치먼트 패널의 상품화 : 암 특이적 인리치먼트 패널의 발매에 의해 암 영역에서 NGS의 응용이 가속하고 있습니다. 이 패널은 주요 암 유전자와 돌연변이를 표적으로 하고 있으며, 종양 성장을 가속하는 유전자 변화를 정확하게 검출할 수 있기 때문에 조기 진단과 치료 전략이 개선됩니다.
• 액체생검 솔루션 확대 : 액체생검용으로 조정된 NGS 프로브의 개발이 급증하고 있습니다. 액체생검은 암 환자를 모니터링하기 위한 비침습적인 방법을 제공하며, 표적 인리치먼트 프로브와 NGS의 통합은 혈액 샘플로부터의 돌연변이의 검출과 종양 프로파일링을 강화합니다.
• 프로브 화학의 혁신 : 합성 생물학 및 CRISPR 기반 기술의 사용과 같은 프로브 화학의 진보는 인리치먼트 반응의 효율성을 향상시키고 있습니다. 이러한 혁신은 임상 및 연구 응용 분야에 필수적인 보다 신속한 납기와 비용 효율적인 시퀀싱으로 이어지고 있습니다.
• 신흥 시장에서의 약사 승인 및 상업화 : 각 회사는 인도 및 중국과 같은 신흥 시장에서 NGS 프로브의 규제 승인을 받았습니다. 이것은 임상 진단, 특히 유전자 스크리닝, 감염증 검출, 종양학에서 NGS 기술의 광범위한 채용을 촉진합니다.

프로브 성능 향상, 암 특이적 패널 상용화, 액체생검 솔루션 확대, 프로브 화학 혁신, 규제 진전 등 최근 동향이 NGS 타겟 인리치먼트 프로브 시장의 성장을 가속하고 있습니다. 이러한 개발은 임상 및 연구 응용 분야에서 유전체 시퀀싱의 가용성과 정확성 향상에 기여합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계의 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 NGS 타겟 인리치먼트 프로브 시장 : 유형별

• 개요
• 매력 분석 : 유형별
• 싱글 프로브 : 동향과 예측(2019-2031년)
• 칩 프로브 : 동향과 예측(2019-2031년)

제5장 세계의 NGS 타겟 인리치먼트 프로브 시장 : 용도별

• 개요
• 매력 분석 : 용도별
• 바이오사이언스 기업 : 동향과 예측(2019-2031년)
• 대학 및 연구기관 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 세계의 NGS 타겟 인리치먼트 프로브 시장 : 지역별

제7장 북미의 NGS 타겟 인리치먼트 프로브 시장

• 개요
• 북미의 NGS 타겟 인리치먼트 프로브 시장 : 유형별
• 북미의 NGS 타겟 인리치먼트 프로브 시장 : 용도별
• 미국의 NGS 타겟 인리치먼트 프로브 시장
• 멕시코의 NGS 타겟 인리치먼트 프로브 시장
• 캐나다의 NGS 타겟 인리치먼트 프로브 시장

제8장 유럽의 NGS 타겟 인리치먼트 프로브 시장

• 개요
• 유럽의 NGS 타겟 인리치먼트 프로브 시장 : 유형별
• 유럽의 NGS 타겟 인리치먼트 프로브 시장 : 용도별
• 독일의 NGS 타겟 인리치먼트 프로브 시장
• 프랑스의 NGS 타겟 인리치먼트 프로브 시장
• 스페인의 NGS 타겟 인리치먼트 프로브 시장
• 이탈리아의 NGS 타겟 인리치먼트 프로브 시장
• 영국의 NGS 타겟 인리치먼트 프로브 시장

제9장 아시아태평양의 NGS 타겟 인리치먼트 프로브 시장

• 개요
• 아시아태평양의 NGS 타겟 인리치먼트 프로브 시장 : 유형별
• 아시아태평양의 NGS 타겟 인리치먼트 프로브 시장 : 용도별
• 일본의 NGS 타겟 인리치먼트 프로브 시장
• 인도의 NGS 타겟 인리치먼트 프로브 시장
• 중국의 NGS 타겟 인리치먼트 프로브 시장
• 한국의 NGS 타겟 인리치먼트 프로브 시장
• 인도네시아의 NGS 타겟 인리치먼트 프로브 시장

제10장 기타 지역의 NGS 타겟 인리치먼트 프로브 시장

• 개요
• 기타 지역의 NGS 타겟 인리치먼트 프로브 시장 : 유형별
• 기타 지역의 NGS 타겟 인리치먼트 프로브 시장 : 용도별
• 중동의 NGS 타겟 인리치먼트 프로브 시장
• 남미의 NGS 타겟 인리치먼트 프로브 시장
• 아프리카의 NGS 타겟 인리치먼트 프로브 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 성장 기회 : 유형별
  • 성장 기회 : 용도별
• 세계의 NGS 타겟 인리치먼트 프로브 시장에서의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 합병, 인수, 계약, 제휴, 합작 사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 프로파일

• Competitive Analysis
• Agilent
• Nanjing Vazyme Biotech
• COBIOER
• iGeneTech
• Shanghai Biotechnology

제14장 부록

• 도표 일람
• 표 목록
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel 소개
• 문의

영문목차

The future of the global ngs target enrichment probe market looks promising with opportunities in the bioscience company, universities and research institutes, and other markets. The global ngs target enrichment probe market is expected to grow with a CAGR of 17.1% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine and precision genetic testing. and advancements in genomic research driving adoption of targeted sequencing technologies..

• Lucintel forecasts that, within the type category, chip probes is expected to witness higher growth over the forecast period.
• Within the application category, bioscience companies is expected to witness the higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the NGS Target Enrichment Probe Market

The global NGS target enrichment probe market is evolving with several emerging trends that reflect advancements in genomic research and technology. These trends are helping to meet the growing demand for faster, more accurate, and cost-effective sequencing solutions across various applications, from clinical diagnostics to research in genomics and personalized medicine.

• Rise in Personalized Medicine: As precision medicine grows in popularity, the demand for targeted enrichment probes is increasing. These probes allow for more accurate sequencing of genes associated with specific diseases, enabling personalized treatment strategies for cancer, genetic disorders, and other conditions. This trend is pushing the need for highly specific and efficient NGS probes.
• Technological Advancements in Probe Design: Significant improvements in probe design and chemistry are enhancing the performance of NGS target enrichment. New techniques for better probe hybridization and amplification are leading to higher sensitivity, accuracy, and coverage in genomic sequencing. This is contributing to faster and more cost-effective sequencing, improving the overall efficiency of NGS workflows.
• Increased Focus on Oncology Applications: Cancer genomics is one of the major drivers for the demand for NGS target enrichment probes. With increasing research into cancer's genetic underpinnings, there is a growing need for probes designed to specifically target oncogenes, tumor suppressor genes, and mutations linked to cancer. This focus is pushing the development of probes tailored for various cancer types.
• Integration with Liquid Biopsy: The integration of NGS target enrichment probes with liquid biopsy technologies is revolutionizing cancer diagnosis and monitoring. Liquid biopsy allows for non-invasive sampling of tumor DNA from blood, and the use of enrichment probes in this process helps detect genetic mutations, offering significant advantages in early cancer detection and monitoring.
• Growth in Infectious Disease Research: The increasing prevalence of infectious diseases, especially viral infections like COVID-19, is driving the use of NGS for pathogen detection. Target enrichment probes are being developed to specifically enrich viral genomes, enabling faster and more accurate detection of infections, mutations, and viral load, thus aiding global public health efforts.

These emerging trends, including the growth of personalized medicine, technological innovations in probe design, oncology-focused applications, integration with liquid biopsy, and infectious disease research, are shaping the future of the NGS target enrichment probe market. These advancements are making genomic sequencing faster, more accurate, and more accessible, leading to better patient outcomes and advancing the field of genomic medicine.

Recent Developments in the NGS Target Enrichment Probe Market

Recent developments in the NGS target enrichment probe market reflect the rapid advancements in genomic research and clinical diagnostics. Innovations in probe chemistry, design, and technology are enhancing the performance of NGS, driving demand across various industries, including oncology, infectious disease research, and genetic testing.

• Improved Probe Performance: Companies have introduced next-generation probes that offer improved sensitivity, specificity, and coverage in NGS workflows. These developments are aimed at providing more accurate sequencing results, particularly in complex genomic regions, leading to better diagnostic capabilities for genetic diseases and cancer.
• Commercialization of Cancer-specific Enrichment Panels: The launch of cancer-specific enrichment panels has accelerated the application of NGS in oncology. These panels target key cancer genes and mutations, enabling precise detection of genetic alterations that drive tumor growth, thus improving early diagnosis and treatment strategies.
• Expansion of Liquid Biopsy Solutions: There has been a surge in the development of NGS probes tailored for liquid biopsy applications. Liquid biopsy offers a non-invasive method for monitoring cancer patients, and the integration of NGS with target enrichment probes enhances the detection of mutations and tumor profiling from blood samples.
• Technological Innovations in Probe Chemistry: Advances in probe chemistry, such as the use of synthetic biology and CRISPR-based methods, have improved the efficiency of enrichment reactions. These innovations are leading to faster turnaround times and more cost-effective sequencing, which is crucial for clinical and research applications.
• Regulatory Approvals and Commercialization in Emerging Markets: Companies have achieved regulatory approvals for their NGS probes in emerging markets such as India and China. This is facilitating the wider adoption of NGS technologies in clinical diagnostics, particularly in genetic screening, infectious disease detection, and oncology.

These recent developments, including the improvement of probe performance, commercialization of cancer-specific panels, expansion of liquid biopsy solutions, innovations in probe chemistry, and regulatory advancements, are driving the growth of the NGS target enrichment probe market. These developments are contributing to the increasing accessibility and accuracy of genomic sequencing for clinical and research applications.

Strategic Growth Opportunities in the NGS Target Enrichment Probe Market

The global NGS target enrichment probe market presents significant growth opportunities, particularly in clinical diagnostics, genomics research, and personalized medicine. As technology advances, companies are developing new strategies to address the growing demand for precise, efficient, and cost-effective sequencing solutions across a variety of applications.

• Opportunities in Cancer Genomics: Cancer genomics represents a major growth opportunity for NGS target enrichment probes. With increasing research into cancer-specific mutations and the growing need for personalized treatment, there is substantial demand for enrichment probes designed to target cancer-related genes, mutations, and biomarkers.
• Expanding Applications in Rare Disease Diagnostics: Rare genetic diseases require highly specialized diagnostic tools. NGS target enrichment probes tailored for rare disease genes present a growth opportunity, enabling faster and more accurate diagnosis and treatment options, especially in underserved populations.
• Personalized Medicine Market Growth: As personalized medicine becomes more mainstream, the demand for NGS probes to identify genetic variations that influence treatment response is increasing. Target enrichment probes play a critical role in tailoring treatments for patients, particularly in oncology and pharmacogenomics.
• Growth in Infectious Disease Surveillance: The need for rapid and accurate pathogen detection, particularly for emerging diseases, is creating growth opportunities for NGS target enrichment probes in infectious disease diagnostics. Enrichment probes for viral and bacterial pathogens are essential for genomic surveillance, helping in early detection and outbreak management.
• Emerging Markets Adoption: As NGS technology becomes more accessible, particularly in emerging markets like India, China, and Latin America, there is a growing demand for affordable enrichment probes. This presents opportunities for companies to expand their offerings in these regions, where the demand for genomic diagnostics is rising.

Strategic growth opportunities in cancer genomics, rare disease diagnostics, personalized medicine, infectious disease surveillance, and emerging market adoption are key drivers shaping the future of the NGS target enrichment probe market. These opportunities are creating avenues for innovation and expansion, enabling more precise and accessible genomic sequencing solutions worldwide.

NGS Target Enrichment Probe Market Driver and Challenges

The global NGS target enrichment probe market is influenced by several drivers and challenges that impact the growth and adoption of genomic technologies. These include technological advancements, regulatory factors, and the growing demand for precision medicine, alongside challenges related to cost, scalability, and regulatory compliance.

The factors responsible for driving the Global NGS Target Enrichment Probe market include:

1. Technological Advancements in NGS: The continuous improvements in NGS technology, including higher throughput and greater accuracy, are driving the demand for efficient target enrichment probes. These advancements help make sequencing more accessible and cost-effective across various clinical and research applications.

2. Rising Demand for Precision Medicine: As the field of personalized medicine expands, the need for targeted sequencing and enrichment probes to identify genetic mutations for individualized treatments grows. This demand is pushing innovations in the probe market to support the precise treatment of genetic conditions and cancer.

3. Increase in Cancer Genomics Research: The growing focus on cancer research and personalized oncology treatments is fueling demand for NGS probes. Cancer-specific enrichment probes are essential for accurate detection of genetic mutations and driver genes, contributing to better diagnostic and therapeutic outcomes.

4. Expanding Applications in Genetic Disease Testing: The increasing focus on genetic disease screening and diagnosis is driving the use of NGS target enrichment probes. These probes help identify mutations related to rare genetic diseases, accelerating diagnosis and treatment.

5. Regulatory Support for Genomic Testing: Governments and healthcare organizations are increasingly supporting the use of genomic technologies for diagnostics, which is driving market growth. Regulatory approvals for NGS-based tests are opening new opportunities for enrichment probes in clinical applications.

Challenges in the Global NGS Target Enrichment Probe market are:

1. High Cost of NGS Technologies: Despite technological advancements, the high cost of NGS platforms and enrichment probes remains a significant barrier to widespread adoption, particularly in low- and middle-income countries.

2. Complex Regulatory Landscape: Regulatory hurdles, such as the approval processes for genomic testing kits and probes, can slow market growth. Different countries have varying standards, making it challenging for companies to meet international compliance requirements.

3. Scalability and Supply Chain Issues: The growing demand for NGS technology presents challenges in scaling production of high-quality enrichment probes. Ensuring a stable supply chain, particularly for raw materials and manufacturing capacity, remains a key challenge for the industry.

The drivers of technological advancements, rising demand for precision medicine, and expanding applications in cancer and genetic disease testing are shaping the NGS target enrichment probe market. However, challenges related to cost, regulatory hurdles, and scalability must be addressed for sustained market growth.

List of NGS Target Enrichment Probe Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ngs target enrichment probe companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ngs target enrichment probe companies profiled in this report include-

• Agilent
• Nanjing Vazyme Biotech
• COBIOER
• iGeneTech
• Shanghai Biotechnology

NGS Target Enrichment Probe Market by Segment

The study includes a forecast for the global ngs target enrichment probe market by type, application, and region.

NGS Target Enrichment Probe Market by Type [Value from 2019 to 2031]:

• Single Probe
• Chip Probe

NGS Target Enrichment Probe Market by Application [Value from 2019 to 2031]:

• Bioscience Company
• Universities And Research Institutes
• Others

NGS Target Enrichment Probe Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the NGS Target Enrichment Probe Market

The global NGS (Next-Generation Sequencing) target enrichment probe market is evolving rapidly, with significant developments in countries like the United States, China, Germany, India, and Japan. These nations are leading advancements in genomic research, particularly in areas like precision medicine, cancer genomics, and personalized healthcare. The increasing demand for more efficient, accurate, and cost-effective solutions for targeted sequencing is driving growth in the NGS target enrichment probe market.

• United States: In the United States, the NGS target enrichment probe market is witnessing substantial growth driven by innovations in genomic research and personalized medicine. Companies like Illumina and Thermo Fisher are expanding their offerings of targeted enrichment solutions for various applications, including cancer genomics, genetic disorders, and microbiome research. There is also a strong focus on improving the efficiency of enrichment protocols, which has led to the development of high-throughput, accurate, and cost-effective probes for NGS.
• China: China is rapidly becoming a key player in the NGS target enrichment probe market, with substantial government investments in genomics and biotechnology. The Chinese government is actively promoting genomics-based healthcare solutions, including precision medicine and genomic screening. Local companies such as BGI are advancing NGS technologies, including the development of high-quality target enrichment probes for a variety of applications, particularly in population genomics and cancer research. This growth is being fueled by an increasing number of sequencing centers and partnerships with international organizations.
• Germany: Germany is at the forefront of NGS target enrichment probe development, with strong support from both academic and private sectors. The country is a leader in medical research, particularly in genomics, and companies like Biozym and Qiagen are playing a significant role in the NGS probe market. Research collaborations and clinical applications are driving demand for specialized enrichment probes, particularly for oncology and rare genetic diseases. Moreover, Germany's focus on precision medicine and personalized healthcare has spurred the development of advanced sequencing probes.
• India: India's NGS target enrichment probe market is gaining traction, particularly with the growing emphasis on affordable genomic research and diagnostics. With rising healthcare costs and a large patient population, India is focusing on making precision medicine and genomic testing more accessible. Local companies, alongside global leaders like Illumina, are developing cost-effective NGS target enrichment probes tailored to the Indian market. The application of these probes in cancer research, infectious diseases, and genetic disorders is accelerating, supported by increasing government and private-sector investments in genomics.
• Japan: Japan has been making significant strides in the NGS target enrichment probe market, driven by strong research and development (R&D) capabilities and a high level of expertise in genomic medicine. Companies like Takara Bio and Sysmex are pioneering the development of advanced target enrichment solutions for NGS applications. Japan's focus on healthcare innovation, especially in oncology, rare diseases, and genetic disorders, has led to a growing demand for high-quality, efficient enrichment probes to enhance the accuracy of sequencing technologies.

Features of the Global NGS Target Enrichment Probe Market

• Market Size Estimates: Ngs target enrichment probe market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Ngs target enrichment probe market size by type, application, and region in terms of value ($B).
• Regional Analysis: Ngs target enrichment probe market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the ngs target enrichment probe market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ngs target enrichment probe market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ngs target enrichment probe market by type (single probe and chip probe), application (bioscience company, universities and research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global NGS Target Enrichment Probe Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Single Probe: Trends and Forecast (2019-2031)
• 4.4 Chip Probe: Trends and Forecast (2019-2031)

5. Global NGS Target Enrichment Probe Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Bioscience Company: Trends and Forecast (2019-2031)
• 5.4 Universities and Research Institutes: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global NGS Target Enrichment Probe Market by Region

7. North American NGS Target Enrichment Probe Market

• 7.1 Overview
• 7.2 North American NGS Target Enrichment Probe Market by type
• 7.3 North American NGS Target Enrichment Probe Market by application
• 7.4 United States NGS Target Enrichment Probe Market
• 7.5 Mexican NGS Target Enrichment Probe Market
• 7.6 Canadian NGS Target Enrichment Probe Market

8. European NGS Target Enrichment Probe Market

• 8.1 Overview
• 8.2 European NGS Target Enrichment Probe Market by type
• 8.3 European NGS Target Enrichment Probe Market by application
• 8.4 German NGS Target Enrichment Probe Market
• 8.5 French NGS Target Enrichment Probe Market
• 8.6 Spanish NGS Target Enrichment Probe Market
• 8.7 Italian NGS Target Enrichment Probe Market
• 8.8 United Kingdom NGS Target Enrichment Probe Market

9. APAC NGS Target Enrichment Probe Market

• 9.1 Overview
• 9.2 APAC NGS Target Enrichment Probe Market by type
• 9.3 APAC NGS Target Enrichment Probe Market by application
• 9.4 Japanese NGS Target Enrichment Probe Market
• 9.5 Indian NGS Target Enrichment Probe Market
• 9.6 Chinese NGS Target Enrichment Probe Market
• 9.7 South Korean NGS Target Enrichment Probe Market
• 9.8 Indonesian NGS Target Enrichment Probe Market

10. ROW NGS Target Enrichment Probe Market

• 10.1 Overview
• 10.2 ROW NGS Target Enrichment Probe Market by type
• 10.3 ROW NGS Target Enrichment Probe Market by application
• 10.4 Middle Eastern NGS Target Enrichment Probe Market
• 10.5 South American NGS Target Enrichment Probe Market
• 10.6 African NGS Target Enrichment Probe Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global NGS Target Enrichment Probe Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Agilent
  • Company Overview
  • NGS Target Enrichment Probe Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Nanjing Vazyme Biotech
  • Company Overview
  • NGS Target Enrichment Probe Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 COBIOER
  • Company Overview
  • NGS Target Enrichment Probe Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 iGeneTech
  • Company Overview
  • NGS Target Enrichment Probe Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Shanghai Biotechnology
  • Company Overview
  • NGS Target Enrichment Probe Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us